Rewiring the DNA of Securities Fraud Litigation: Amgen's Missed Opportunity

19 Pages Posted: 25 Jun 2013 Last revised: 26 Sep 2013

Date Written: May 8, 2013

Abstract

This Essay, a contribution to a fall 2012 "Behavioral Economics and Investor Protection" symposium sponsored by Loyola-Chicago's Institute for Investor Protection (IIP), argues that securities fraud doctrine needs to be rebuilt. The lessons of behavioral economics undercut several of the key elements of the modern Rule 10b-5 securities fraud claim - including current approaches to materiality, scienter, and reliance. Drawing on my previous work on substantive tort law and securities fraud, I sketch the beginnings of a reformed approach in which securities fraud class actions would be modeled less on common law fraud than on deceptive and false advertising claims.

Keywords: securities fraud, Amgen, reliance, materiality, scienter, recklessness

JEL Classification: K22

Suggested Citation

Rapp, Geoffrey Christopher, Rewiring the DNA of Securities Fraud Litigation: Amgen's Missed Opportunity (May 8, 2013). Loyola University Chicago Law Journal, Vol. 44, No. 5, 2013, University of Toledo Legal Studies Research Paper No. 2013-14, Available at SSRN: https://ssrn.com/abstract=2282742

Geoffrey Christopher Rapp (Contact Author)

University of Toledo College of Law ( email )

2801 W. Bancroft Street
Toledo, OH 43606
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
69
Abstract Views
684
Rank
598,765
PlumX Metrics